Evidence for population-based BRCA1 and BRCA2 screening for ovarian cancer prevention

被引：0
|
作者：
Levy-Lahad, E. [1 ]
Gabai-Kapara, E. [1 ]
Kaufman, B. [2 ]
Catane, R. [2 ]
Segev, S. [3 ]
Renbaum, P.
Beller, U. [4 ]
King, M. C. [5 ,6 ]
Lahad, A. [7 ]
机构：
[1] Hebrew Univ Jerusalem, Sch Med, Inst Med Genet, Shaare Zedek Med Ctr, IL-91010 Jerusalem, Israel
[2] Chaim Sheba Med Ctr, Div Oncol, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Inst Med Screening, IL-52621 Tel Hashomer, Israel
[4] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel
[5] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA
[6] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[7] Hebrew Univ Jerusalem, Sch Med, Dept Family Med, IL-91010 Jerusalem, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2012年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [21] Economic evaluation of population-based BRCA1 and BRCA2 testing in Canada
    Sun, L.
    Wei, X.
    Fierheller, C. T.
    Dawson, L.
    Oxley, S.
    Kalra, A.
    Sia, J.
    Feldman, F.
    Peacock, S.
    Schrader, K. A.
    Legood, R.
    Kwon, J. S.
    Manchanda, R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 61 - 61
  • [22] Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada
    Sun, Li
    Wei, Xia
    Fierheller, Caitlin T.
    Dawson, Lesa
    Oxley, Samuel
    Kalra, Ashwin
    Sia, Jacqueline
    Feldman, Fabio
    Peacock, Stuart
    Schrader, Kasmintan A.
    Legood, Rosa
    Kwon, Janice S.
    Manchanda, Ranjit
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [23] A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention
    Hanley, Gillian E.
    McAlpine, Jessica N.
    Miller, Dianne
    Huntsman, David
    Schrader, Kasmintan A.
    Gilks, C. Blake
    Mitchell, Gillian
    BMC CANCER, 2018, 18
  • [24] A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention
    Gillian E. Hanley
    Jessica N. McAlpine
    Dianne Miller
    David Huntsman
    Kasmintan A. Schrader
    C. Blake Gilks
    Gillian Mitchell
    BMC Cancer, 18
  • [25] Population-based BRCA1 and BRCA2 testing in Canada: an economic evaluation
    Sun, Li
    Wei, Xia
    Fierheller, Caitlin T.
    Dawson, Lesa
    Oxley, Samuel
    Kalra, Ashwin
    Sia, Jacqueline
    Feldman, Fabio
    Peacock, Stuart
    Schrader, Kasmintan A.
    Legood, Rosa
    Kwon, Janice
    Manchanda, Ranjit
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A52 - A53
  • [26] Population genetics of BRCA1 and BRCA2
    Szabo, CI
    King, MC
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (05) : 1013 - 1020
  • [27] Cancer screening distress among a clinic-based population of BRCA1 and BRCA2 carriers
    Wenzel, L.
    Osann, K.
    Kurz, R.
    Karlan, B.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S107 - S108
  • [28] Frequency of pathogenic variants in BRCA1 and BRCA2 genes in a Russian population-based sample and in patients with breast or ovarian cancer
    Limonova, Alena
    Meshkov, Alexey
    Ershova, Alexandra
    Kiseleva, Anna
    Skirko, Olga
    Klimushina, Marina
    Sotnikova, Evgeniia
    Kurilova, Olga
    Efimova, Irina
    Lyubchenko, Ludmila
    Filippova, Margarita
    Poloznikov, Andrey
    Kutsenko, Vladimir
    Pokrovs-Kaya, Maria
    Drapkina, Oxana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 373 - 373
  • [29] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [30] Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer
    Wenham, RM
    Schildkraut, JM
    McLean, K
    Calingaert, B
    Bentley, RC
    Marks, J
    Berchuck, A
    CLINICAL CANCER RESEARCH, 2003, 9 (12) : 4396 - 4403
12345